Pharmaceuticals News
Cencora Surges 5% Ahead of Fed Minutes as Futures Turn Mixed
Cencora (CENC) jumped 5.04% as mixed US stock futures flagged investor uncertainty ahead of key Federal Reserve minutes.
Oct 8, 2026
๐บ๐ธ United StatesNovo Nordisk Plunges as Morgan Stanley Warns Semaglutide Patent Cliff Is Worse Than Markets Think
Morgan Stanley downgraded NVO to Underweight, citing semaglutide patent cliff risks from compounded competition and biosimilar development that the market has not adequately priced into Novo Nordisk's valuation.
Sep 12, 2026
๐บ๐ธ United StatesQuoin Pharmaceuticals Surges 38.5% Premarket on $50 Million Capital Raise Despite Unprofitability
Quoin Pharmaceuticals (QNRX) stock surged 38.5% premarket after announcing a $50 million capital raise
Aug 29, 2026
KiniksaKiniksa Pharmaceuticals Shares Rise as Rilonacept Commercial Momentum Continues in Pericarditis
Kiniksa Pharmaceuticals rose approximately 3% as rilonacept commercial momentum in recurrent pericarditis continues, with Arcalyst the only FDA-approved treatment in the indication.
Aug 18, 2026
AmylyxAmylyx Pharmaceuticals Surges 17% as Investors Position Ahead of Avexitide Clinical Data
Amylyx Pharmaceuticals surged 17% ahead of avexitide clinical data for congenital hyperinsulinism, a rare pediatric metabolic disorder with limited treatment options.
Aug 18, 2026
๐บ๐ธ United StatesImmunic Inc. Faces Post-Earnings Headwinds as EPS Miss and Low GF Score Signal Financial Challenges
Immunic Inc. (IMUX) reported quarterly earnings that missed EPS estimates, reinforcing concerns about the clinical-stage biopharmaceutical company's path to profitability
Aug 13, 2026
๐บ๐ธ United StatesDrugs Made In America Acquisition Corp. Enters Material Agreement: SEC 8-K Signals SPAC Milestone
Drugs Made In America Acquisition Corp. filed an 8-K disclosing entry into a material definitive agreement (Item 1.01), a significant milestone in its SPAC lifecycle.
Jul 21, 2026
๐ฎ๐ณ IndiaCipla, Britannia and HUL Break Above Key EMAs in Broad India FMCG-Pharma Technical Breakout
Cipla, Britannia, and HUL simultaneously broke above key exponential moving averages Monday, signaling broad defensive sector rotation in Indian equities.
Jul 20, 2026
KoreaCelltrion Secures Sole AAA Korea Customs Export Safety Rating Among Pharma Firms
Celltrion, South Korea's largest biosimilar maker, maintained its AAA-grade export safety management certification from Korea Customs Service, remaining the only pharmaceutical or biotech company among 773 certified firms to hold the top rating.
Jul 15, 2026
PharmaceuticalsAbbVie Acquisition of Evommune Reshapes Immunology Startup Outlook with Full Development Infrastructure Access
AbbVie's acquisition of Evommune, a clinical-stage immunology startup, materially improves the target company's development outlook by providing access to AbbVie's global clinical infrastructure and commercial capabilities for inflammatory skin condition programs.
Jun 23, 2026
PharmaceuticalsEli Lilly Receives Approval for Centessa Pharmaceuticals Acquisition Expanding Specialty Pipeline
Eli Lilly received regulatory or contractual approval for its acquisition of Centessa Pharmaceuticals, adding clinical-stage drug candidates to complement the company's market-leading GLP-1 franchise as it deploys capital beyond obesity and diabetes.
Jun 23, 2026
Us StocksCentury of Returns: Why Pharma Outperformed Oil in a 29,000-Stock Study
A study of 29,078 US stocks from 1925 to 2023 finds pharmaceuticals as a superior long-term buy-and-hold sector.
Jun 14, 2026